ALZN - Alzamend Neuro, Inc. Stock Price, Fair Value and News

$2.06+0.01 (+0.49%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

ALZN Price Action

Last 7 days

-8.0%

Last 30 days

-18.9%

Last 90 days

-9.2%

Trailing 12 Months

-81.7%

ALZN RSI Chart

ALZN Valuation

Market Cap

6.5M

Price/Earnings (Trailing)

-1.03

Price/Free Cashflow

-0.82

ALZN Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ALZN Fundamentals

ALZN Earnings

Earnings (TTM)

-6.3M

Earnings Growth (Yr)

-177.37%

Earnings Growth (Qtr)

-142.91%

ALZN Profitability

Return on Equity

-117.34%

Return on Assets

-99.1%

Free Cashflow Yield

-121.75%

ALZN Investor Care

Shares Dilution (1Y)

626.43%

Diluted EPS (TTM)

-4.91

Revenue & Growth

About Alzamend Neuro, Inc.

Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

CEO	Mr. Stephan Jackman
WEBSITE	alzamend.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	4

Alzamend Neuro, Inc. Frequently Asked Questions

What is the ticker symbol for Alzamend Neuro, Inc.? What does ALZN stand for in stocks?

ALZN is the stock ticker symbol of Alzamend Neuro, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Alzamend Neuro, Inc. (ALZN)?

As of Wed Dec 03 2025, market cap of Alzamend Neuro, Inc. is 6.47 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ALZN stock?

You can check ALZN's fair value in chart for subscribers.

Is Alzamend Neuro, Inc. a good stock to buy?

The fair value guage provides a quick view whether ALZN is over valued or under valued. Whether Alzamend Neuro, Inc. is cheap or expensive depends on the assumptions which impact Alzamend Neuro, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ALZN.